Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, childhood acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2026-07-29		NCT06184009

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ajou University School of Medicine	19
Asan Medical Center	114
Inha University Hospital	15
Jae Wook Lee	1
Korea University Anam Hospital	54
Pusan National University Yangsan Hospital	43
Samsung Medical Center	207
Seoul National University Hospital	277
Severance Hospital	45

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ajou University Hospital	Suwon	South Korea	40
Asan Medical Center	Seoul	South Korea	338
Inha University Hospital	Incheon	South Korea	35
Korea University Anam Hospital	Seoul	South Korea	94
Pusan National University Yangsan Hospital	Yangsan	South Korea	30
Samsung Medical Center	Seoul	South Korea	2
Seoul National University Hospital	Seoul	South Korea	31
Seoul saint Mary's Hospital	Seoul	South Korea	4
Severance Hospital	Seoul	South Korea	81